Login / Signup

Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis.

Isabelle BonnetAntoine RousseauPierre DuraffourJacques PouchotChi Duc NguyenEric GabisonRaphaele SerorHubert MarotteXavier MarietteGaetane Nocturne
Published in: RMD open (2021)
RTX appears to be an efficient and safe therapeutic option in the treatment of RA-associated PUK.
Keyphrases
  • rheumatoid arthritis
  • disease activity
  • diffuse large b cell lymphoma
  • ankylosing spondylitis
  • interstitial lung disease
  • systemic lupus erythematosus
  • combination therapy
  • smoking cessation